Pfizer CentreOne Capacity Update May 2024: Small Molecule Finished Dosage Form

As an award winning global CDMO, Pfizer CentreOne uses Pfizer’s extensive scientific and technical expertise to manufacture OSD medicines for pharmaceutical and biotech companies like yours. Leveraging Pfizer's decades of experience and cutting-edge development & commercial manufacturing solutions, we offer a wide range of OSD platform manufacturing and packaging formats. Our services are designed to help provide the optimum balance between product customization and effective and reliable supply.

In this session from the May 2024 OPCU event, Senior Business Development Manager, Liam Heath, highlights Pfizer CentreOne’s overall small molecule capabilities, with a focus on our ability to help meet your complex Oral Solid Dose needs. From pellets, tablets, and capsules to innovative release profiles, Pfizer CentreOne has the global expertise to help meet your needs across a wide range of platforms and technologies.